Published in

Elsevier, Gastroenterology, 5(154), p. 1343-1351.e1, 2018

DOI: 10.1053/j.gastro.2018.01.004

Links

Tools

Export citation

Search in Google Scholar

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease

Journal article published in 2018 by Geert D’Haens ORCID, Severine Vermeire, Guy Lambrecht, Filip Baert, Peter Bossuyt, Benjamin Pariente, Anthony Buisson ORCID, Yoram Bouhnik, Jérôme Filippi, Janneke vander Woude, Philippe Van Hootegem ORCID, Jacques Moreau, Edouard Louis, Denis Franchimont, Martine De Vos and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO